| abstract |
Acute coronary syndrome (ACS), particularly acute myocardial infarction (AMI) and angina, wherein provasopressin (proAVP) or fragments and partial peptides thereof, particularly copeptin or neurophysin II, are measured by in-vitro diagnosis A method for risk stratification of (AP) is provided. Provasopressin (proAVP) or fragments and partial peptides thereof, particularly copeptin or neurophysin II, which are highly sensitive and specific for the diagnosis of acute coronary syndrome, are measured by in-vitro diagnosis. [Selection figure] None |